Basiliximab application on liver recipients: a meta-analysis of randomized controlled trials.

Zhang, Guo-Qing; Zhang, Cheng-Shuo; Sun, Ning; Lv, Wu; Chen, Bao-Min; Zhang, Jia-Lin

Zhang, Guo-Qing; Zhang, Cheng-Shuo; Sun, Ning; Lv, Wu; Chen, Bao-Min; Zhang, Jia-Lin.

Affiliation

Zhang GQ; Department of Hepatobiliary and Transplantation Surgery, First Affiliated Hospital of China Medical University, Shenyang 110001, China. jlz2000@yeah.net.

Hepatobiliary Pancreat Dis Int ; 16(2): 139-146, 2017 Apr.

Article in En | MEDLINE | ID: mdl-28381376

Subject(s)

Antibodies, Monoclonal/therapeutic use; Graft Rejection/prevention & control; Graft Survival/drug effects; Immunosuppressive Agents/therapeutic use; Liver Transplantation; Recombinant Fusion Proteins/therapeutic use; Adult; Aged; Antibodies, Monoclonal/adverse effects; Basiliximab; Biopsy; Chi-Square Distribution; Diabetes Mellitus/etiology; Diabetes Mellitus/prevention & control; Drug Therapy, Combination; Female; Graft Rejection/immunology; Graft Rejection/mortality; Humans; Hypertension/etiology; Hypertension/prevention & control; Immunosuppressive Agents/adverse effects; Liver Transplantation/adverse effects; Liver Transplantation/mortality; Male; Middle Aged; Odds Ratio; Recombinant Fusion Proteins/adverse effects; Risk Factors; Treatment Outcome; Young Adult

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Recombinant Fusion Proteins / Liver Transplantation / Graft Rejection / Graft Survival / Immunosuppressive Agents / Antibodies, Monoclonal Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hepatobiliary Pancreat Dis Int Year: 2017 Document type: Article

Search on Google

XML

PubMed Links